Navigation Links
Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
Date:3/8/2013

sup>® and take other medicines that increase your risk of bleeding, including:

  • Aspirin or aspirin-containing products
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Warfarin sodium (Coumadin®, Jantoven®)
  • Any medicine that contains heparin
  • Clopidogrel (Plavix®)
  • Other medicines to prevent or treat blood clots

Tell your doctor if you take any of these medicines. Ask your doctor or pharmacist if you are not sure if your medicine is one listed above.

Call your doctor or get medical help right away if you develop any of these signs or symptoms of bleeding:

  • Unexpected bleeding or bleeding that lasts a long time such as:
    • Nosebleeds that happen often
    • Unusual bleeding from gums
    • Menstrual bleeding that is heavier than normal, or vaginal bleeding
  • Bleeding that is severe or that you cannot control
  • Red, pink, or brown urine
  • Bright red or black stools (looks like tar)
  • Cough up blood or blood clots
  • Vomit blood or your vomit looks like "coffee grounds"
  • Headaches, feeling dizzy or weak
  • Pain, swelling, or new drainage at wound sites

Spinal or epidural blood clots (hematoma):  People who take a blood thinner medicine (anticoagulant) like XARELTO®, and have medicine injected into their spinal and epidural area, or have a spinal puncture have a risk of forming a blood clot than can cause long-term or permanent loss of the ability to move (paralysis). Your risk of developing a spinal or epidural blood clot is higher if:

  • A thin tube called an epidural catheter is placed in your back to give you certain medicine

  • '/>"/>

SOURCE Janssen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
2. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
3. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
4. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
5. West Announces Agreement with Janssen Biotech to Develop and Commercialize a New Self-injection Technology
6. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
7. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
8. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
11. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... -- Organovo Holdings, Inc. (NYSE MKT: ONVO; "Organovo"), a three-dimensional ... announced today that the company will present at an ... be held in New York , ... Chairman and Chief Executive Officer, will deliver a company ... Details of the presentations are as follows: ...
(Date:5/26/2015)... , May 26, 2015  RXi Pharmaceuticals ... company focused on discovering and developing innovative ... and ophthalmology, today announced that the Company,s President ... will present at the Jefferies 2015 Global ... at 11:30 a.m. EDT. Dr. Cauwenbergh will ...
(Date:5/26/2015)... May 26, 2015 For the ... Quality of Life Throughout Europe, the Middle ... Astellas Pharma EMEA is celebrating its 10 ... through the historic merger of Japanese pharmaceutical companies Yamanouchi ... committed to turning science into value for patients through ...
Breaking Medicine Technology:Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 2Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 3RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 2RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 3RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 4Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4
... N.J., Jan. 31, 2011 Nephros, Inc. (OTC Bulletin ... developing and marketing filtration products for therapeutic applications, infection ... statement on Form S-1 for its previously announced rights ... January 31, 2011 by the Securities and Exchange Commission. ...
... FALMOUTH, Mass., Jan. 31, 2011 Associates of ... its NEW CHROMOGENIC ENDOTOXIN DETECTION SYSTEM incorporating the ... Kinetix® Flex Incubating Kinetic tube reader. This system ... testing. ACC,s enhanced Pyrochrome® is ...
Cached Medicine Technology:Nephros Rights Offering Registration Statement Declared Effective 2Nephros Rights Offering Registration Statement Declared Effective 3Nephros Rights Offering Registration Statement Declared Effective 4New Chromogenic Endotoxin Detection System 2
(Date:5/26/2015)... Award-winning travel photographer and life coach Raul Espinoza creates ... connect viewers to the beauty of the world while making ... Raul has traveled the world documenting lives, and then shared ... bounded by our circumstances. , “KAWSAY” means “life” ... The photo gallery show by the same name will support ...
(Date:5/26/2015)... 2015 On June 4, 2015, ... online broadcast at 6:00pm PST/9:00 pm EST. This ... Alice Branton welcomes the public to attend and invite ... profound knowledge, transformation and enlightenment. The webinar is ... previous knowledge, experience or other prerequisites are required. , ...
(Date:5/26/2015)... DENVER (May 26, 2015) – As the nation’s ... experiencing many of the growing pains felt by other ... issue that cannabis companies now have to grapple with ... plastic that marijuana growers, dispensaries and consumers go through ... the opportunity to enhance our environment for the benefit ...
(Date:5/26/2015)... Janesville, WI (PRWEB) May 26, 2015 ... - Schrader is responsible for using her quality ... Care ’s day-to-day operations. Denise also provides leadership and ... of Mercy Hospice Care, Mercy Home Health Care and ... of experience in health care administration with the last ...
(Date:5/26/2015)... The professionals from Marietta Vet Clinic ... helping local rescue pets with a parking lot cookout ... Kimmerling DDS, Suzanna Aguilera DMD and Garrick McGrath DMD ... 100% of proceeds from the extravaganza. , Tents, grills ... to help save unwanted, local animals. Doctors and ...
Breaking Medicine News(10 mins):Health News:A Photographer & Two Educational Organiazations Join to Make a Difference in Our Youth 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 3Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 3Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2
... release is available in French and Spanish ... menopause two years earlier than healthy women, a study ... although further study is required, researchers have found at least ... postmenopausal women. Osteoporosis in the hip increases the risk ...
... researchers have found that liver transplant recipients who quit ... than patients who keep smoking. In fact, SRMs were ... associated with a higher risk of malignancy in this ... of Liver Transplantation , a journal of the ...
... March 29 (HealthDay News) -- Enhanced cleaning of hospital ... aureus (MRSA) infection for patients placed in a room ... finds. MRSA is a a type of staph ... MRSA rates among patients admitted to 10 ICUs at ...
... to increase your chances of losing weight, reduce your stress level ... people trying to lose at least 10 pounds were more likely ... slept more than six hours but not more than eight hours ... Journal of Obesity , was the result of a study funded ...
... Severely obese men and women who have bariatric surgery may ... much of their pre-surgery risk for experiencing disabling migraines, researchers ... a small study of obese patients with a history of ... roughly 66 pounds by the half-year point following either laparoscopic ...
... antigen (PSA)-based prostate cancer screening in the United States found ... screenings. Using data from surveys conducted in 2000 and 2005, ... underwent PSA screening in the past year almost double ... are more likely to benefit from early prostate cancer diagnosis ...
Cached Medicine News:Health News:Gene combinations are found to be related to hip osteoporosis in postmenopausal women 2Health News:Smoking in combination with immunosuppression poses greater risk for transplant-related carcinoma 2Health News:Better Cleaning in ICUs Lowers MRSA Infection Rates 2Health News:Moderate sleep and less stress may help with weight loss 2Health News:Moderate sleep and less stress may help with weight loss 3Health News:Weight-Loss Surgery May Cut Migraine Pain in Obese Patients 2Health News:Weight-Loss Surgery May Cut Migraine Pain in Obese Patients 3Health News:Researchers find many elderly men are undergoing unnecessary PSA screenings 2Health News:Researchers find many elderly men are undergoing unnecessary PSA screenings 3
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea....
For Frontalis Suspension in patients with significant ptosis and poor levator function....
For enucleation/evisceration....
... A new Transnasal Lacrimal Stent has been ... B. Becker, M.D., the Transnasal Lacrimal Stent addressed ... and other forms of endoscopic DCR. Brought in ... relatively large diameter. Because there is no need ...
Medicine Products: